These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 11920475

  • 1. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm).
    Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SP, Kashani-Sabet M.
    Cancer; 2002 Feb 15; 94(4):1049-56. PubMed ID: 11920475
    [Abstract] [Full Text] [Related]

  • 2. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O, Akslen LA.
    Cancer; 1996 Sep 15; 78(6):1211-9. PubMed ID: 8826942
    [Abstract] [Full Text] [Related]

  • 3. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.
    Arch Dermatol; 2008 Apr 15; 144(4):462-7. PubMed ID: 18427039
    [Abstract] [Full Text] [Related]

  • 4. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass LF.
    J Am Acad Dermatol; 2001 May 15; 44(5):762-6. PubMed ID: 11312421
    [Abstract] [Full Text] [Related]

  • 5. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D, Borgognoni L, Franchi A, Martini L, Reali UM, Santucci M.
    Melanoma Res; 2000 Apr 15; 10(2):153-64. PubMed ID: 10803716
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
    Sartore L, Papanikolaou GE, Biancari F, Mazzoleni F.
    Int J Surg; 2008 Jun 15; 6(3):205-9. PubMed ID: 18417434
    [Abstract] [Full Text] [Related]

  • 7. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM.
    Arch Dermatol; 2005 Aug 15; 141(8):1016-22. PubMed ID: 16103331
    [Abstract] [Full Text] [Related]

  • 8. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL.
    Ann Surg Oncol; 2007 May 15; 14(5):1604-11. PubMed ID: 17333418
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y.
    Cancer; 2003 Mar 15; 97(6):1488-98. PubMed ID: 12627514
    [Abstract] [Full Text] [Related]

  • 14. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
    Gutzmer R, Satzger I, Thoms KM, Völker B, Mitteldorf C, Kapp A, Bertsch HP, Kretschmer L.
    J Dtsch Dermatol Ges; 2008 Mar 15; 6(3):198-203. PubMed ID: 18093216
    [Abstract] [Full Text] [Related]

  • 15. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
    Paek SC, Griffith KA, Johnson TM, Sondak VK, Wong SL, Chang AE, Cimmino VM, Lowe L, Bradford CR, Rees RS, Sabel MS.
    Cancer; 2007 Jan 01; 109(1):100-8. PubMed ID: 17146784
    [Abstract] [Full Text] [Related]

  • 16. The role of microsatellites as a prognostic factor in primary malignant melanoma.
    Shaikh L, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR, Kashani-Sabet M.
    Arch Dermatol; 2005 Jun 01; 141(6):739-42. PubMed ID: 15967920
    [Abstract] [Full Text] [Related]

  • 17. The complex relationships between sentinel node positivity, patient age, and primary tumor desmoplasia: analysis of 2303 melanoma patients treated at a single center.
    Sassen S, Shaw HM, Colman MH, Scolyer RA, Thompson JF.
    Ann Surg Oncol; 2008 Feb 01; 15(2):630-7. PubMed ID: 18080717
    [Abstract] [Full Text] [Related]

  • 18. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY, Tufaro AP, Manson PN.
    Ann Plast Surg; 2003 Jun 01; 50(6):601-6. PubMed ID: 12783009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.